Oncothyreon Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: biomachine56 who wrote (2183)

5/28/2013 11:11:53 PM

From: biomachine56

Read Replies (1) of 2344

PX-866 patent filings May 23, 2013

appft1.uspto.gov

United States Patent Application	20130129720
Kind Code	A1
Peterson; Scott ; et al.	May 23, 2013

Combination Cancer Therapies with Wortmannin Analogs

AbstractProvided herein are combination therapies for the treatment of certain cancers in a subject by administering a combination of a therapeutic and a wortmannin analog to that subject.

appft1.uspto.gov

United States Patent Application	20130131156
Kind Code	A1
Peterson; Scott ; et al.	May 23, 2013

Cancer Treatment with Wortmannin Analogs

AbstractProvided herein are certain therapeutically effective dosing regimens for treatment of cancers with wortmannin analogs.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next